Viewing Study NCT03257267


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-05-05 @ 8:03 AM
Study NCT ID: NCT03257267
Status: COMPLETED
Last Update Posted: 2025-04-08
First Post: 2017-07-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Cemiplimab in Adults With Cervical Cancer
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma (SCC) View
None Recurrent or Metastatic, Platinum-refractory Cervical Cancer View
Keywords: